Supplementary Experiment
Synthesis of 6-azapurines 5a-t by ring contraction of toxoflavins 1a-t
1, [1, 2, 4] 
triazin-6(5H)-one 5a
A solution of 1,6-dimethylpyrimido [5,4-e] [1,2,4]triazine-5,7(1H,6H)-dione 1a (0.5 g, 2.6 mmol) in 10% aqueous NaOH solution (10 mL) was stirred at 5-10 °C for 3 days. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water and concentrated to dryness in vacuo. The residue was crystallized from a mixture of EtOH/H 2 O to give the pure 6-azapurine derivative 5a [12] (380 mg, 89%) as colorless needles. 3, NaOH solution (10 mL) was stirred at 5-10 °C for 3 days. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water and concentrated to dryness in vacuo. The residue was crystallized from a mixture of EtOH/H 2 O to give the pure 6-azapurine derivative 5b (294 mg, 68%) as colorless needles.
1,

3-Ethyl-1,5-dimethyl-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5c
A solution of 3-ethyl-1,6-dimethylpyrimido [5,4-e] [1,2,4]triazine-5,7(1H,6H)-dione 1c (0.5 g, 2.3 mmol) in 10% aqueous NaOH solution (10 mL) was stirred at 5-10 °C for 3 days. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water and concentrated to dryness in vacuo. The residue was crystallized from a mixture of EtOH/H 2 O to give the pure 6-azapurine derivative 5c (183 mg, 42%) as colorless needles. , [1, 2, 4] 
1
triazin-6(5H)-one 5d
A solution of 1,6-dimethyl-3-(n-propyl)pyrimido [5,4-e] [1,2,4]triazine-5,7(1H,6H)-dione 1d (0.5 g, 2.1 mmol) in 10%
aqueous NaOH solution (10 mL) was stirred at room temperature for 1 day. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water and concentrated to dryness in vacuo. The residue was crystallized from a mixture of EtOH/H 2 O to give the pure 6-azapurine derivative 5d (203 mg, 46%) as colorless needles. aqueous NaOH solution (10 mL) was stirred at room temperature for 1 day. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water and concentrated to dryness in vacuo. The residue was crystallized from a mixture of EtOH/H 2 O to give the pure 6-azapurine derivative 5e (233 mg, 53%) as colorless needles.
3-
1,5-Dimethyl-3-pheny-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5f
A solution of
aqueous NaOH solution (10 mL) was heated with stirring at 60-70 °C for 15 min. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water to afford the solid. The solid was collected by filtration and washed with H 2 O and recrystallized from EtOH to give the pure 6-azapurine derivative 5f (358 mg, 80%) as colorless needles.
3-(4-Fluorophenyl)-1,5-dimethyl-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5g
A solution of 3-(4-fluorophenyl)-1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione 1g (0.5 g, 1.7 mmol) in 10% aqueous NaOH solution (10 mL) was heated with stirring at 60-70 °C for 10 min. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water to afford the solid. The solid was collected by filtration and washed with H 2 O and recrystallized from EtOH to give the pure 6-azapurine derivative 5g (284 mg, 63%) as colorless needles.
3-(3-Chlorophenyl)-1,5-dimethyl-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5h
10% aqueous NaOH solution (10 mL) was heated with stirring at 60-70 °C for 15 min. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water to afford the solid. The solid was collected by filtration and washed with H 2 O and recrystallized from EtOH to give the pure 6-azapurine derivative 5h (209 mg, 46%) as colorless needles.
3-(4-Chlorophenyl)-1,5-dimethy-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5i
A solution of 3-(4-chlorophenyl)-1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione 1i (0.5 g, 1.6 mmol) in 10% aqueous NaOH solution (10 mL) was heated with stirring at 60-70 °C for 15 min. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water to afford the solid. The solid was collected by filtration and washed with H 2 O and recrystallized from EtOH to give the pure 6-azapurine derivative 5i (182 mg, 40%) as colorless needles.
3-(4-Bromophenyl)-1,5-dimethyl-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5j
A solution of 3-(4-bromophenyl)-1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione 1j (0.5 g, 1.4 mmol) in 10% aqueous NaOH solution (10 mL) was heated with stirring at 60-70 °C for 20 min. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water to afford the solid. The solid was collected by filtration and washed with H 2 O and recrystallized from EtOH to give the pure 6-azapurine derivative 5j (267 mg, 58%) as colorless needles.
3-(4-Hydroxyphenyl)-1,5-dimethyl-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5k
A solution of 3-(4-hydroxyphenyl)-1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione 1k (0.5 g, 1.8 mmol) in 10% aqueous NaOH solution (15 mL) was heated with stirring at 60-70 °C for 20 min. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water to afford the solid. The solid was collected by filtration and washed with H 2 O and recrystallized from EtOH to give the pure 6-azapurine derivative 5k (226 mg, 50%) as colorless needles. and recrystallized from EtOH to give the pure 6-azapurine derivative 5l (275 mg, 61%) as colorless needles.
1,5-Dimethyl-3-(p-tolyl)-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5l
3-(4-Isopropylphenyl)-1,5-dimethyl-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5m
A solution of 3-(4-isopropylphenyl)-1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione 1m (0.5 g, 1.6 mmol)
in 10% aqueous NaOH solution (15 mL) was heated with stirring at 60-70 °C for 20 min. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water to afford the solid. The solid was collected by filtration and washed with H 2 O and recrystallized from EtOH to give the pure 6-azapurine derivative 5m (332 mg, 73%) as colorless needles.
3-(4-Methoxyphenyl)-1,5-dimethyl-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5n
A solution of 3-(4-methoxyphenyl)-1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione 1n (0.5 g, 1.7 mmol) in 10% aqueous NaOH solution (15 mL) was heated with stirring at 60-70 °C for 15 min. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water to afford the solid. The solid was collected by filtration and washed with H 2 O and recrystallized from EtOH to give the pure 6-azapurine derivative 5n (344 mg, 76%) as colorless needles.
3-(3,4-Dimethoxyphenyl)-1,5-dimethyl-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5o
A solution of 3-(3,4-dimethoxyphenyl)-1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione 1o (0.5 g, 1.5 mmol) in 10% aqueous NaOH solution (15 mL) was heated with stirring at 60-70 °C for 20 min. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water to afford the solid. The solid was collected by filtration and washed with H 2 O and recrystallized from EtOH to give the pure 6-azapurine derivative 5o (352 mg, 77%) as colorless needles.
3- (3, 4, 3-(4-Acetoxyphenyl) -1,5-dimethyl-1H-imidazo[4,5-e][1,2,4] 
triazin-6(5H)-one 5q
A solution of 3-(4-acetoxyphenyl)-1,6-dimethylpyrimido [5,4-e] [1,2,4]triazine-5,7(1H,6H)-dione 1q (0.5 g, 1.5 mmol) in 10% aqueous NaOH solution (20 mL) was heated with stirring at 60-70 °C for 30 min. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water to afford the solid. The solid was collected by filtration and washed with H 2 O and recrystallized from EtOH to give the pure 6-azapurine derivative 5q (247 mg, 54%) as yellow needles.
1,5-Dimethyl-3-(4-(dimethylamino)phenyl)-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5r
A solution of 1,6-dimethyl-3-(4-(dimethylamino)phenyl)pyrimido [5,4-e] [1,2,4]triazine-5,7(1H,6H)-dione 1r (0.5 g, 1.6 mmol) in 10% aqueous NaOH solution (20 mL) was heated with stirring at 60-70 °C for 45 min. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water to afford the solid. The solid was collected by filtration and washed with H 2 O and recrystallized from EtOH to give the pure 6-azapurine derivative 5r (214 mg, 47%) as yellow needles.
3-(2-Furyl)-1,5-dimethyl-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5s
A solution of 3-(2-furyl)-1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione 1s (0.5 g, 1.9 mmol) in 10%
aqueous NaOH solution (20 mL) was heated with stirring at 60-70 °C for 45 min. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water to afford the solid. The solid was collected by filtration and washed with H 2 O and recrystallized from EtOH to give the pure 6-azapurine derivative 5s (326 mg, 73%) as colorless needles.
1,5-Dimethyl-3-(2-thienyl)-1H-imidazo[4,5-e][1,2,4]triazin-6(5H)-one 5t
A solution of 1,6-dimethyl-3-(2-thienyl)pyrimido [5,4-e] [1,2,4]triazine-5,7(1H,6H)-dione 1t (0.5 g, 1.8 mmol) in 10%
aqueous NaOH solution (20 mL) was heated with stirring at 60-70 °C for 1h. Then, the solution was adjusted to pH 7 with 10% HCl under cooling on ice-water to afford the solid. The solid was collected by filtration and washed with H 2 O and recrystallized from EtOH to give the pure 6-azapurine derivative 5t (377 mg, 84%) as colorless needles.
